Dear Applicants and Supporters of the 2025 Rohto Awards HK,
Rohto Advanced Research Hong Kong LTD (ARHK) would like to extend our sincere gratitude to everyone who submitted an application or expressed interest in the 2025 Rohto Awards HK. We were greatly encouraged by the enthusiastic response.
As the result of internal consideration, we have made the decision to discontinue the 2025 Rohto Awards program and the application review process will not proceed.
We sincerely apologize for any inconvenience or disappointment this decision may cause. We recognize the significant effort invested by each applicant, and we deeply regret that we cannot move forward with the awards as planned.
While the formal awards program is concluded, our commitment to fostering innovation in healthcare R&D remains strong. Our team was particularly impressed by the quality and creativity of many submissions. Our team may proactively contact a select number of applicants in the coming weeks to discuss possibilities for direct collaboration, outside the scope of the original awards framework.
We believe the end of this program can be the beginning of new, meaningful partnerships. We remain dedicated to advancing healthcare innovation and value the connections made through this initiative.
We thank you once again for your interest and participation. For any inquiries regarding this notice, please contact us at research@arhk.rohto.com
Sincerely,
The Rohto Advanced Research Hong Kong (ARHK) Team
back